EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Separation and quantification of novel synthetic regioisomeric fentanyls in clinical extracts by high pH reverse-phase LC-MS/MS

Benjamin S. Barrett, Jennifer K. Field, Erika Sitch, William H. Campbell, Melvin R. Euerby, Oliver B. Sutcliffe

Forensic Chemistry · 2026-03 · 47 · 100721

DOI: 10.1016/j.forc.2025.100721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Forensic Chemistry, 2026-03. Verfasst von Benjamin S. Barrett und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pennsylvania State University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study compares three different chromatographic methods used for the separation of regioisomeric fluorofentanyl, as described in previous literature, through application to clinical whole blood extracts. A high pH, RP-UHPLC-MS/MS method was selected and a series of opioids ( n = 23), including regioisomeric series of fluorofentanyl, despropionylfluorofentanyl, and fluoroisobutyrylfentanyl ( n = 13), fentanyl and other fentanyl analogues ( n = 8), heroin and xylazine, were successfully validated against UKAS LAB51 and SWGTOX guidelines using this method. The results of the validation demonstrated R 2 greater than 0.99 for all analytes except heroin ( n = 22), accuracy ranging from 96.8 % to 110.1 % and precision between 0.8 % to 13.2 % as percentage coefficient of variation across replicate injections ( n = 9) of three different quality control levels for all analytes except heroin (n = 22). Limits of detection ranged from 0.016 ng/mL to 0.24 ng/mL and limits of quantification ranged from 0.049 ng/mL to 0.729 ng/mL. Clinical whole blood extracts were screened by high-resolution mass spectrometry and triaged for further identification and quantification of regioisomeric compounds where an unknown regioisomeric form of fluorofentanyl was found. Across all sample extracts para -fluorofentanyl was successfully identified, alongside potential interferences including other drugs of abuse (cocaine, methamphetamine, gabapentin) and cutting agents (procaine, lidocaine), and quantified within the range of 0.44 ng/mL to 31.16 ng/mL, with fentanyl, para -despropionylfluorofentanyl, and 4-ANPP detected and quantified in all samples with para -fluorofentanyl. • Comparison of chromatography for quantifying regioisomeric fluorofentanyls. • Partial method validation complying with SWGTOX guidelines. • Screening of extracts by high-resolution mass spectrometry for fluorofentanyl. • Quantification of previously unidentified fluorofentanyl.

Förderung

  • Pennsylvania State University

Zitieren

APA

Barrett, B. S., Field, J. K., Sitch, E., Campbell, W. H., Euerby, M. R., & Sutcliffe, O. B. (2026). Separation and quantification of novel synthetic regioisomeric fentanyls in clinical extracts by high pH reverse-phase LC-MS/MS. Forensic Chemistry, 47, 100721. https://doi.org/10.1016/j.forc.2025.100721

Vancouver

Barrett BS, Field JK, Sitch E, Campbell WH, Euerby MR, Sutcliffe OB. Separation and quantification of novel synthetic regioisomeric fentanyls in clinical extracts by high pH reverse-phase LC-MS/MS. Forensic Chemistry. 2026;47:100721. doi:10.1016/j.forc.2025.100721

BibTeX
@article{Barrett2026,
  author = {Barrett, Benjamin S. and Field, Jennifer K. and Sitch, Erika and Campbell, William H. and Euerby, Melvin R. and Sutcliffe, Oliver B.},
  title = {Separation and quantification of novel synthetic regioisomeric fentanyls in clinical extracts by high pH reverse-phase LC-MS/MS},
  journal = {Forensic Chemistry},
  year = {2026},
  volume = {47},
  pages = {100721},
  doi = {10.1016/j.forc.2025.100721}
}
Kostenlos starten →